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Objectives. This study investigated the efficacy of four different
methods of arterial puncture site management during recovery
from invasive cardiac procedures. The primary goals were less
patient discomfort and improved clinical outcome.
Background. The increasing use of outpatient catheterization,
large interventional devices and potent periprocedural anticoag-
ulation regimens has made the reduction of groin complications a
high priority. Despite these trends, there are no randomized trials
comparing commonly used techniques in treating the catheter
entry site for the first few hours after the procedure.
Methods. Four-hundred consecutive patients undergoing cath-
eterization laboratory procedures were randomly assigned to one
of four dressing techniques applied after achieving hemostasis: a
sandbag placed over the site; a pressure dressing constructed
from surgical gauze and elastic tape; a commercially available
compression device; and no use of compressive dressing. Of these
400 patients, 171 would have been eligible for outpatient proce-
dures in the absence of geographic constraints. The dressings
were removed, and ambulation was encouraged 5 h after sheath
removal. Uniform initial compression times, patient instructions,
nursing follow-up and a structured interview and physical exam-
ination at 24 h were used.
Results. The level of patient discomfort before and after dress-
ing removal, as well as site tenderness at 24-h follow-up, was
statistically similar in all four groups. Hematomas (typically
small) and areas of ecchymosis were observed in 58 and 122
patients, respectively, but both their frequency and size were
equally represented in each group. Important adverse events were
confined to bleeding, rated as mild in 5.8%, moderate in 0.8% and
severe in 0.6% of patients. Again, all four groups were statistically
similar. Comparable findings were observed in the subgroup of
patients eligible for outpatient procedures.
Conclusions. Despite an increase in inconvenience and expense,
none of the three compression techniques that were investigated
improved patient satisfaction or outcome. Therefore, the routine
use of compression dressings after invasive cardiac procedures
cannot be recommended.
(J Am Coll Cardiol 1997;30:444–51)
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Cardiac catheterization and related procedures continue to
increase in frequency of use, safety and performance in an
outpatient setting. The majority of diagnostic catheterizations
can be performed in the modern era without sedation, and
recovery of most organ systems is nearly immediate. However,
the universal requirement of arterial access substantially pro-
longs the requisite period of immobility and monitoring and
remains the single most important impediment to early ambu-
lation and discharge. Moreover, a significant portion of the
costs associated with these procedures is expended during this
recovery period.
A number of attempts have been made to minimize the
impact and complications of this obligate arteriotomy. Over
the past decade the size of diagnostic and therapeutic catheters
has steadily decreased, allowing a smaller rent in the arterial
wall (1–5). Another advocated approach is to gain arterial
access through a site less stressed by ambulation, such as the
brachial, radial or axillary arteries (6–10). Widespread appli-
cation has been slow to catch on, though, as these upper
extremity vessels are less conveniently accessed in most cath-
eterization laboratories and can limit the size of the devices
used. Collagen plugs and modified surgical closure devices are
undergoing premarket and aftermarket testing in an attempt to
speed initial hemostasis (11–16), but whether this accelerated
hemostasis will translate to earlier recovery remains unclear.
Nearly all previous efforts at promoting early ambulation
have focused on techniques related to sheath insertion or
withdrawal. In contrast, scant attention has been paid to
speeding ambulation, reducing complications and limiting pain
and inconvenience through techniques that exert the most
influence after the patient leaves the catheterization labora-
tory. The current randomized study seeks to discover whether
any of four potential methods of managing the arteriotomy site
for the first few hours after catheterization will prove superior.
This comparison is facilitated by close monitoring both before
and after ambulation and by the use of a structured interview
and physical evaluation 24 h after the procedure.
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Methods
Patient group. Subjects were selected from consecutive
patients undergoing invasive arterial procedures in the cardiac
catheterization laboratory. The following exclusion criteria
were applied: 1) arterial access at a site other than the right or
left femoral artery; 2) emergent procedure; 3) arterial punc-
ture at the same femoral site within the previous 18 h; 4)
continued use or effect of warfarin, heparin, thrombolytic
agent, ticlopidine, abciximab or other nonaspirin anticoagulant
agent at the time of the procedure; 5) vascular perforation,
thrombosis or hematoma formation occurring during the pro-
cedure; 6) timing of the procedure that would preclude staff
availability over the following 24 h; and 7) unwillingness or
inability to provide written, informed consent. Overall, 400
patients were enrolled. Three were terminated before
follow-up because of inappropriate enrollment (hematoma
present before sheath removal). In addition, follow-up data
were incomplete in 38 patients (often because of unanticipated
early discharge); these individuals were included in all analyses
except for outcomes. Power calculations were done to ensure
an adequate sample size for the detection of clinically mean-
ingful differences between groups. Based on a two-tailed alpha
value of 0.95, the power (1 2 b) of the study to detect a
one-point difference in pain scale was 0.95; a 2.5-min difference
in time to hemostasis was 0.97; a 20% difference in the
proportion of patients with rebleeding was 0.99; and a 30%
difference in the proportion of patients reporting site tender-
ness was 0.99.
Study protocol. The overall study consisted of a prospec-
tive, randomized trial of arteriotomy site management based
on a three-by-four factorial design. The first phase consisted of
randomized assignment to one of three techniques used to
achieve initial hemostasis (manual hold, clamp and inflatable
compression device). In the second phase, representing the
subject of this report, we studied four different methods of
maintaining hemostasis outside of the catheterization labora-
tory, referred to as “dressing technique.” Randomization was
accomplished using a computer-generated random number
sequence and a sealed envelope system of assignment. The
four groups are described below, with treatment initiated
immediately after achieving adequate hemostasis after sheath
removal: 1) “sandbag”—a 4.5-kg (10-lb), 32-cm 3 12-cm 3
8-cm sandbag placed directly over the site. 2) “Pressure
dressing”—six 10 3 10-cm, 12-ply, sterile gauze sponges folded
once both vertically and horizontally (final dimensions 5 5 3
5 cm) positioned directly over the site. This was held in place
by 30-cm strips of 8-cm wide elastic adhesive bandage (Elas-
toplast, Belerdorf, Inc.). Two strips were stretched from the
iliac crest to the ipsilateral inner thigh, and a third strip was
placed perpendicularly from the symphysis pubis to the midline
of the lateral thigh. The dressing was applied with the hip
flexed and externally rotated ;20° to increase pressure on the
arteriotomy site on leg straightening (17,18). 3) “Compression
device”—a commercially available product (HOLD device,
Pressure Products, Inc.) that consists of an 8-cm diameter
hemispheric polystyrene disk held under tension against the
arteriotomy site by a belt system extending around both the
waist and the upper thigh. 4) “None”—the site was not treated
with any compression dressing. All dressings were scheduled
for removal 5 h after sheath removal, and ambulation was
started shortly thereafter. The protocol was approved by the
Human Studies Committee of the University of Washington,
Seattle.
Study procedures. Vascular access sheaths were used in
every patient, ranging in size from 5F to 10F. Patients under-
going diagnostic procedures were typically treated with
2,000 U of intravenous heparin immediately after sheath
insertion. A heparin bolus dose of 10,000 to 15,000 U was used
for interventional procedures and was followed by repeated
boluses as needed to maintain an activated clotting time of 250
to 350 s. No patient received protamine sulfate for reversal of
anticoagulation. The sheaths were removed immediately after
the diagnostic procedures. For interventional procedures,
sheath removal occurred 4 to 20 h after completion, and after
discontinuation of heparin and documentation of an activated
clotting time ,150 s. Before application of the randomly
selected dressing, each arterial access site was carefully in-
spected for evidence of hematoma formation or other vascular
problems, and measurements of size were made as appropri-
ate. All patients received a small, sterile adhesive strip (Band-
aid) to cover the puncture site before placement of the
compression dressing.
Uniform verbal and written instructions of immobility were
given to each patient at the time of transfer from the cathe-
terization laboratory. Written nursing orders included frequent
vital sign checks and bed rest for 5 h with the head of the bed
elevated ,30°. As part of the study, the nursing team caring for
the patient made a special effort to document bleeding,
discomfort and deviations from the prescribed activity plan.
Five hours after sheath removal all dressings were removed,
and all medically able patients were strongly encouraged to
ambulate at a level commensurate with their normal activities
at home. Approximately 24 h after sheath removal, all patients
were interviewed and examined by a single observer. Discom-
fort was rated on a 1 to 10 scale, where 1 5 barely noticeable
discomfort and 10 5 maximal degree of pain the patient has
experienced or could imagine. A hematoma was recorded as
present if focal induration .1 cm in diameter was palpated at
the puncture site, with the size computed as an elliptical
surface area using orthogonal measurements as major and
minor axes. The size of any ecchymotic area was similarly
measured and computed. Arterial occlusion, arteriovenous
fistula and pseudoaneurysm formation were recorded as a
major adverse event if surgical correction was required within
1 year of the original procedure.
Data analysis. All analyses were performed on an intention-
to-treat basis. Data are presented as mean value 6 SD.
Differences in categoric variables were compared using the
chi-square test, and differences in continuous variables were
compared using the Kruskal-Wallace analysis of variance. A
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probability value of 0.05 was accepted as the limit of statistical
significance.
Results
Baseline characteristics. The clinical characteristics for the
study group (n 5 397) are presented in Table 1. Most were
men with a mean age of 61 years. Previous myocardial infarc-
tion was present in 39% of patients. Risk factors for athero-
sclerosis were common, including hypertension in 53%, diabe-
tes in 25%, a history of current or past smoking in 52% and a
history of hypercholesterolemia in 36% of patients. The prev-
alence of peripheral vascular disease (bruits, claudication
and/or previous vascular surgery) was 27%. Importantly, these
characteristics were evenly divided between the four study
groups.
Hemodynamic and angiographic variables were also equally
distributed between the groups. Central systolic and pulse
pressures, representing hemodynamic forces that might influ-
ence arteriotomy site rebleeding, averaged 128 and 59 mm Hg,
respectively. Overall, 29% of enrollees lacked significant an-
giographic coronary artery disease, most of whom received
invasive evaluation for valvular or other forms of heart disease.
Because of its hyperdynamic effect on blood pressure, the
presence of aortic regurgitation can make the achievement and
maintenance of hemostasis more difficult; this condition was
present in five patients (two in the “pressure dressing” group
and one each in the other three groups).
Procedure-related variables. The distributions of procedure-
related variables are shown in Table 2. The arterial sheath
diameter ranged from 5F to 10F, with 7F the most frequent
size used. The sheath was inserted directly through prosthetic
vascular bypass graft material in a small number of patients
(7%) (19). The majority of procedures (92%) were diagnostic,
with the remainder interventional. After the procedure, 68%
of patients returned to the cardiology ward and 32% to an
intensive care unit bed.
As part of the study protocol, a target minimal arterial
compression time of 13 min after sheath removal was estab-
lished. The actual mean time to hemostasis in each group
ranged from 14.3 to 14.9 min. Before the dressing could be
applied, minor rebleeding was noted in 6.3% of patients, and
small hematomas (not present before sheath removal) were
observed in 11.1%. Again, there were no statistically significant
differences between the groups with regard to any of these
variables.
Outcomes. All patients who were medically able were
encouraged to ambulate as they would at home starting 5 h
after sheath removal. Of the 287 patients (80%) who did, their
level of activity at 24 h was self-described as mild in 72%,
average (normal daily activity) in 25% and strenuous in 3%. In
general, each of the dressing techniques used was well toler-
ated. The mean level of discomfort (on a scale of 1 to 10)
during dressing use was 1.8 6 1.8 for the “none” group, 1.7 6
1.6 for the “sandbag” group, 1.7 6 1.5 for the “pressure
dressing” group and 1.8 6 1.4 for the “compression device”
Table 1. Baseline Characteristics of Study Group
Group According to Dressing Type
None
(n 5 89)
Sandbag
(n 5 105)
Pressure Dressing
(n 5 96)
Compression Device
(n 5 107)
Clinical variables
Age (yr) 61 6 11 63 6 11 60 6 10 61 6 10
Male gender 86 (97) 105 (100) 92 (96) 106 (99)
Body surface area (m2) 2.04 6 0.21 2.03 6 0.17 2.04 6 0.21 2.05 6 0.20
Historic variables
Previous MI 32 (36) 49 (47) 45 (47) 29 (27)
Hypertension 50 (56) 55 (52) 46 (48) 61 (57)
Diabetes 18 (20) 29 (28) 25 (26) 27 (25)
Smoking 45 (51) 51 (49) 50 (52) 60 (56)
Hypercholesterolemia 25 (28) 37 (35) 37 (39) 42 (39)
Peripheral vascular disease 25 (28) 31 (30) 20 (21) 32 (30)
Hemodynamic/angiographic variables
Heart rate (beats/min) 71 6 14 68 6 11 72 6 14 70 6 12
Systolic pressure (mm Hg) 127 6 20 127 6 23 125 6 20 133 6 27
Pulse pressure (mm Hg) 57 6 17 59 6 20 56 6 18 62 6 21
Ejection fraction (%) 58 6 14 56 6 16 58 6 19 61 6 14
No. vessels with CAD
None 38 (43) 19 (18) 29 (30) 27 (25)
One 8 (9) 14 (13) 20 (21) 17 (16)
Two 19 (21) 26 (25) 19 (20) 28 (26)
Three 24 (27) 46 (44) 28 (29) 35 (33)
Mean no. vessels with CAD 1.33 6 1.28 1.94 6 1.14 1.48 6 1.21 1.66 6 1.18
Data are presented as mean value 6 SD or number (%) of patients or vessels. There were no statistically significant
differences between the groups. CAD 5 coronary artery disease (.50% stenosis); MI 5 myocardial infarction.
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group (p 5 0.69). The mean discomfort level in each group
remained low after the dressing was removed, both before (p 5
0.46) and during (p 5 0.80) ambulation (Fig. 1).
A physical examination at 24 h showed site tenderness to be
both uncommon (31%) and, when present, mostly mild (77%).
Severe tenderness was found in only five patients (three of
whom were in the “pressure dressing” group). A new hema-
toma at the site was recorded in an average of 12% of patients
in each group, covering a mean surface area of 6.9 6 18.4 cm2
(Fig. 2). Ecchymoses were more common—found in 37%,
26%, 36% and 38% of the four groups (p 5 0.25), as shown in
Table 3 and Figure 3.
Figure 1. Cumulative distribution of the
degree of discomfort reported by each
patient during dressing use (left panel)
and after dressing removal (right panel).
None of the differences observed were
statistically significant.
Table 2. Procedure-Related Variables
Group According to Dressing Type
None Sandbag Pressure Dressing Compression Device
Sheath size
5F, 6F 4 (5) 3 (3) 1 (1) 1 (1)
7F 75 (84) 88 (84) 85 (89) 92 (86)
8F 2 (2) 7 (7) 6 (6) 6 (6)
9F, 10F 8 (9) 7 (7) 4 (4) 8 (8)
Sheath insertion site
Native artery 85 (96) 96 (91) 90 (94) 97 (91)
Prosthetic graft 4 (5) 9 (9) 6 (6) 10 (9)
Type of procedure
Diagnostic 78 (88) 100 (95) 89 (93) 97 (91)
Interventional 11 (12) 5 (5) 7 (7) 10 (9)
Postprocedural monitoring
Intensive care unit 32 (36) 35 (33) 26 (27) 36 (34)
Cardiology ward 57 (64) 70 (67) 70 (73) 71 (66)
Sheath removal
By catheterization
laboratory technician
79 (89) 87 (83) 77 (80) 82 (77)
By catheterization
laboratory/ICU nurse
10 (11) 17 (16) 16 (17) 23 (22)
By physician 0 (0) 1 (1) 3 (3) 2 (2)
Time to hemostasis (min) 14.9 6 4.6 14.3 6 3.5 14.3 6 3.8 14.7 6 5.0
Hematoma before dressing 14 (16) 8 (8) 7 (7) 15 (14)
Rebleed before dressing 4 (5) 7 (7) 8 (8) 6 (6)
Data are presented as mean value 6 SD or number (%) of patients. There were no statistically significant differences
between the groups.
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Adverse events occurred in a total of 26 patients. This
consisted of mild rebleeding in 21 (5.8%), moderate rebleeding
in 3 (0.8%), and severe rebleeding in 2 (0.6%). Although
rebleeding was least common in the “pressure dressing” group,
the rates of rebleeding were not statistically different between
the groups. Arterial occlusion was not observed, and surgical
vascular repair was not required in any patient within 1 year of
the catheterization procedure.
Taken together, these findings show no benefit, either
subjective or objective, with the use of any of the three
compressive dressing techniques.
Discussion
Relation to outpatient catheterization. At the time of the
study, all catheterization procedures undertaken in our labo-
ratory were performed on an inpatient basis, due in large part
to the four-state catchment area served by the laboratory. This
provided a unique opportunity to study and closely monitor
many patients who would be eligible for outpatient catheter-
ization in the absence of geographic constraints. Patients were
continually available for monitoring and evaluation for at least
24 h after their invasive procedure, maximizing the likelihood
that suboptimal results and adverse outcomes would be fully
detected and appropriately assessed. As part of this protocol,
all participants were encouraged to ambulate 5 h after sheath
removal at a level commensurate with their anticipated activity
at home, had they been discharged. Overall, 287 patients
(80%) did successfully ambulate. Of these, 6 (2%) experienced
Figure 2. The measured size of all hematomas seen at the 24-h
follow-up examination, grouped by the type of dressing used. None of
the differences observed were statistically significant. Mean values are
indicated by open circles.
Table 3. Outcome Statistics for Type of Dressing
Group According to Dressing Type
None Sandbag Pressure Dressing Compression Device p Value
Level of ambulation 0.76
None 14 (18) 16 (17) 17 (21) 25 (25)
Mild 50 (63) 53 (55) 50 (60) 53 (53)
Average 13 (17) 25 (26) 14 (17) 19 (19)
Strenuous 2 (3) 3 (3) 2 (2) 3 (3)
Mean level of discomfort
During dressing 1.8 6 1.8 1.7 6 1.6 1.7 6 1.5 1.8 6 1.4 0.69
After dressing (before ambulation) 1.8 6 1.8 1.3 6 0.9 1.6 6 1.3 1.5 6 1.1 0.46
After dressing (during ambulation) 1.8 6 1.8 1.6 6 1.3 1.7 6 1.2 1.7 6 1.7 0.80
Site tenderness at follow-up 0.11
None 51 (65) 70 (72) 53 (64) 73 (73)
Mild 26 (33) 24 (25) 21 (25) 18 (18)
Moderate 2 (3) 2 (2) 6 (7) 8 (8)
Severe 0 (0) 1 (1) 3 (4) 1 (1)
Site appearance
New hematoma present 11 (14) 13 (13) 8 (10) 12 (12) 0.79
Ecchymosis present 29 (37) 25 (26) 30 (36) 38 (38) 0.25
Adverse events
Rebleed 8 (10) 9 (9) 2 (2) 7 (7) 0.22
Mild 7 (88) 8 (89) 1 (50) 5 (71)
Moderate 0 (0) 1 (11) 1 (50) 1 (14)
Severe 1 (13) 0 (0) 0 (0) 1 (14)
Arterial occlusion 0 (0) 0 (0) 0 (0) 0 (0)
Vascular surgery 0 (0) 0 (0) 0 (0) 0 (0)
Transfusion 0 (0) 0 (0) 0 (0) 1 (1) 0.44
Data are presented as mean value 6 SD or number (%) of patients. All differences were statistically not significant.
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some bleeding after they started to ambulate, but there were
no differences between the groups in the frequency of late
bleeding. In addition to the primary analyses presented earlier,
we assessed outcomes in the subgroup of enrollees who might
be considered for outpatient procedures (no unstable angina
or interventional procedures) (20). The results obtained from
these 171 individuals were the same as for the overall study
group, except for a slightly lower frequency of hematoma
formation with the use of a sandbag (offset by a slightly higher
frequency of hematoma formation with sandbag use in nonam-
bulatory patients). Thus, our findings of a lack of improved
efficacy with any of the compression techniques studied appear
applicable to outpatient procedures as well.
Importance of puncture site management. Since its incep-
tion in 1950 (21), the use of left heart catheterization has
expanded greatly in frequency, scope and safety. These im-
provements are attributable in large part to the tremendous
advances in techniques and devices used for this and related
procedures. However, over the same period little has changed
in the approach to postprocedural arterial puncture site man-
agement. To date, no randomized trial has been published that
investigates this universal problem. As a result, considerable
differences can be found in the recommended approach to this
problem, detailed in standard texts (22–25). The most common
recommendation, though, involves puncture site compression
with a sandbag or pressure dressing for several hours after the
procedure (22).
This topic is gaining importance for a number of reasons.
First, the last decade has witnessed a major shift worldwide
from inpatient to outpatient catheterization. These patients
must be able to ambulate quickly and safely. Second, early
discharge for inpatients undergoing an intervention has been
promoted and practiced as a way to control medical expenses.
Third, the introduction of certain procedures such as direc-
tional atherectomy, intraaortic balloon counterpulsation and
percutaneous cardiopulmonary bypass has led to an increase in
arterial sheath size used in many patients (26,27). Finally, there
is a growing trend for the in-laboratory use of potent antico-
agulation agents such as ticlopidine and abciximab, not only for
coronary stenting but also during routine balloon angioplasty
procedures (28). As a result of these trends, the rates of
vascular complications have become a principal focus of
several major interventional trials (28).
Potential advantages of compression dressings. Each of
the three compression dressings investigated in this trial has
unique theoretic advantages. Sandbags are simple to apply and
encourage leg immobility by their bulk, but they only exert
diffuse (and therefore minimal) pressure directly on the punc-
ture site and tend to easily slip off the groin site. Pressure
dressings exert considerable direct pressure and are position-
ally stable, but they take time to construct, can result in skin
damage at points of attachment of the adhesive strip and can
hinder visual inspection of the puncture site. The commercially
available compression device addresses some of the shortcom-
ings of the pressure dressings, but it has the disadvantages of
higher expense and an easily soiled support belt system.
None of these shortcomings is of sufficient magnitude to
preclude the use of compression dressings if clinical benefit
results. However, based on the results of the current study,
none proved statistically superior, in terms of clinical outcome
or patient discomfort, to the use of no compression dressing at
all.
Potential study limitations. Several possible limitations of
this trial deserve mention. First, the combination of an inter-
mediate sample size with a low expected frequency of serious
adverse events precludes any statistically meaningful compar-
ison of the rate of major vascular complications between the
groups. Based on an estimated incidence of 1% (29–35), power
studies (using an alpha value of 0.05 and a beta value of 0.10)
suggest that 153,000 patients would be needed to reliably
Figure 3. The measured ecchymotic area for each of the 122
ecchymoses observed at the 24-h follow-up examination,
grouped by the type of dressing used and plotted on a
logarithmic scale. A number of points are superimposed
because of patients with identical ecchymosis areas. None of
the differences observed were statistically significant. Mean
values are indicated by open circles.
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detect a 25% intergroup difference in these complications.
Obviously this sample size would have represented an unreal-
istic target for this trial, and will likely be unattainable in future
studies in this area. Second, the most common size of arterial
sheaths in this study was 7F. Most outpatient catheterizations
done currently in our and other centers routinely use 6F or 5F
sheaths. Although this could potentially affect the absolute
level of discomfort and adverse events reported in this study, it
is likely that a comparison of the relative differences between
compression dressing groups will remain valid for smaller
sheath sizes as well. Hence, our findings should retain their
applicability to the outpatient as well as inpatient setting.
Finally, we have attempted to standardize all variables possi-
ble, including initial hold times, duration of dressing use,
timing and extent of ambulation, patient instructions, evalua-
tion of puncture site before dressing application, quantitation
of hematomas and areas of ecchymosis and heparin use.
Nevertheless, some unmeasured confounding variable could
have skewed our results. The use of random treatment assign-
ment, however, should have minimized this potential error.
Clinical implications. All of the three dressing techniques
investigated in this randomized trial resulted in impaired
visualization of the arteriotomy site, greater use of catheter-
ization laboratory time, higher expense and increased incon-
venience to both the physician and patient. These marginal
disadvantages could be offset by a decrease in discomfort or a
lower complication rate. However, none of the three tech-
niques investigated proved statistically superior to no dressing
at all. Therefore, the routine use of arterial puncture site
compression techniques for either inpatient or outpatient
invasive cardiac procedures cannot be recommended.
We gratefully acknowledge the expert technical assistance provided by Daryl
Jones, CPT, Cary Shepherd, CVT, Ruben Flores, RT, Donna Kline, RN, and
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